Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 28Disease 3Obesity 2Carcinoma, Intraductal, Noninfiltrating 2Women With Breast Cancer 1Prostatic Neoplasms 1Obesity, Morbid 1Neoplasms 1Hypersensitivity 1Fibrocystic Breast Disease 1Digital Breast Tomosynthesis 1Cysts 1Colorectal Neoplasms 1Breast Screening 1Breast Cancer Screening 1Breast Cancer Detection 1Acquired Immunodeficiency Syndrome 1

Interventions

Oxaliplatin 270Bevacizumab 260Fluorouracil 249Irinotecan 240Leucovorin 218Capecitabine 196Cetuximab 161Colonoscopy 74Folfox protocol 70Panitumumab 64regorafenib 62Drug Therapy 52Radiotherapy 50HMPL-013 50Blood Specimen Collection 45trifluridine tipiracil drug combination 43pembrolizumab 41Surveys and Questionnaires 35Standard of Care 35Nivolumab 34Neoadjuvant Therapy 34Surgical Procedures, Operative 33Magnetic Resonance Spectroscopy 31IFL protocol 27Trifluridine 26Interviews as Topic 26Celecoxib 26XELOX 25Early Intervention, Educational 24Specimen Handling 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Colorectal Neoplasms × Mammography × Clear all
NCT04034953 2020-10-12

Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong

Chinese University of Hong Kong

Phase NA Unknown
10,000 enrolled
BreastGastrointestinalGenitourinaryOther

Breast Neoplasms, Obesity, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡